225 related articles for article (PubMed ID: 21953030)
1. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
[TBL] [Abstract][Full Text] [Related]
2. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
3. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
4. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.
Park J; Yang JS; Jung G; Woo HI; Park HD; Kim JW; Huh W; Ko JW; Kim H; Cho JY; Lee SY
J Proteomics; 2013 Dec; 94():302-10. PubMed ID: 24120528
[TBL] [Abstract][Full Text] [Related]
5. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
[TBL] [Abstract][Full Text] [Related]
7. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
[TBL] [Abstract][Full Text] [Related]
8. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
9. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
[TBL] [Abstract][Full Text] [Related]
10. The Haptoglobin β chain as a supportive biomarker for human lung cancers.
Kang SM; Sung HJ; Ahn JM; Park JY; Lee SY; Park CS; Cho JY
Mol Biosyst; 2011 Apr; 7(4):1167-75. PubMed ID: 21253648
[TBL] [Abstract][Full Text] [Related]
11. Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.
Firpo MA; Gay DZ; Granger SR; Scaife CL; DiSario JA; Boucher KM; Mulvihill SJ
World J Surg; 2009 Apr; 33(4):716-22. PubMed ID: 19082654
[TBL] [Abstract][Full Text] [Related]
12. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
13. Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera.
Sung HJ; Jeon SA; Ahn JM; Seul KJ; Kim JY; Lee JY; Yoo JS; Lee SY; Kim H; Cho JY
J Proteomics; 2012 Apr; 75(7):2170-80. PubMed ID: 22300576
[TBL] [Abstract][Full Text] [Related]
14. Analytical validation of commercially available methods for acute phase proteins quantification in pigs.
Tecles F; Fuentes P; Martínez Subiela S; Parra MD; Muñoz A; Cerón JJ
Res Vet Sci; 2007 Aug; 83(1):133-9. PubMed ID: 17141287
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
16. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
Sheu CC; Yu YP; Tsai JR; Chang MY; Lin SR; Hwang JJ; Chong IW
Int J Cancer; 2006 Sep; 119(6):1419-26. PubMed ID: 16642481
[TBL] [Abstract][Full Text] [Related]
17. Nested case control study of proteomic biomarkers for interstitial lung disease in Japanese patients with non-small-cell lung cancer treated with erlotinib: a multicenter phase IV study (JO21661).
Atagi S; Katakami N; Yoshioka H; Fukuoka M; Kudoh S; Ogiwara A; Imai M; Ueda M; Matsui S
Clin Lung Cancer; 2013 Jul; 14(4):407-17. PubMed ID: 23490546
[TBL] [Abstract][Full Text] [Related]
18. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
19. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
20. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
